Edition:
United Kingdom

Aptevo Therapeutics Inc (APVO.OQ)

APVO.OQ on NASDAQ Stock Exchange Global Select Market

5.04USD
24 Sep 2018
Change (% chg)

$0.09 (+1.82%)
Prev Close
$4.95
Open
$4.91
Day's High
$5.09
Day's Low
$4.91
Volume
18,945
Avg. Vol
27,907
52-wk High
$6.30
52-wk Low
$1.92

Chart for

About

Aptevo Therapeutics Inc. is a biotechnology company. The Company is focused on oncology and hematology therapeutics. The Company is engaged in the discovery, development, commercialization and sale of oncology and hematology therapeutics. The Company's technology is the ADAPTIR (modular protein technology) platform. The Company... (more)

Overall

Beta: --
Market Cap(Mil.): $57.83
Shares Outstanding(Mil.): 21.42
Dividend: --
Yield (%): --

Financials

  APVO.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -5.29 -- --
ROI: -122.43 1.79 14.61
ROE: -145.10 3.28 16.33

Earnings vs. Estimates